Fund HoldingsAlly Bridge Group (NY) LLC

Total Portfolio Value
$167.83M
Total Bought
$101.92M
Total Sold
$27.76M
Net Transaction
+$74.16M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
JASPER THERAPEUTICS INC3,144,1643,659,255+515,0912,20128,87217.20%+26,671
ARGENX SE - ADR(ARGX)035,000+35,000013,3157.93%+13,315
SOLENO THERAPEUTICS INC0309,950+309,950012,4757.43%+12,475
CYMABAY THERAPEUTICS INC0489,938+489,938011,5726.90%+11,572
OLEMA PHARMACEUTICALS INC(OLMA)0659,035+659,03509,2465.51%+9,246
ALPINE IMMUNE SCIENCES INC0357,271+357,27106,8104.06%+6,810
AMBRX BIOPHARMA INC0385,383+385,38305,4883.27%+5,488
AVADEL PHARMACEUTICALS-ADR0347,036+347,03604,9002.92%+4,900
HARPOON THERAPEUTICS INC0428,400+428,40004,8712.90%+4,871
MERUS NV221,384274,923+53,5395,2207,5604.50%+2,340
APELLIS PHARMACEUTICALS INC
COM
181,805150,000-31,8056,9168,9795.35%+2,063
XENON PHARMACEUTICALS INC(XENE)266,961241,961-25,0009,11911,1456.64%+2,025
PRAXIS PRECISION MEDICINES I(PRAX)070,424+70,42401,5690.93%+1,569
GERON CORP(GERN)2,221,6392,971,639+750,0004,7106,2703.74%+1,560
INTRA-CELLULAR THERAPIES INC175,000141,348-33,6529,11610,1236.03%+1,008
AXSOME THERAPEUTICS INC(AXSM)110,600100,862-9,7387,7308,0284.78%+298
PROMIS NEUROSCIENCES INC531,9151,066,674+534,7591,0531,2270.73%+173
MEDAVAIL HOLDINGS INC117,897117,89707075290.32%-178
CONTEXT THERAPEUTICS INC725,951725,95101,0968200.49%-276
COMPASS THERAPEUTICS INC914,630834,630-80,0001,8021,3020.78%-500
AMYLYX PHARMACEUTICALS INC(AMLX)272,690275,773+3,0834,9934,0592.42%-934
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)183,105143,479-39,62610,4378,6655.16%-1,772
PRAXIS PRECISION MEDICINES I1,056,3700-1,056,3701,8060-1,806
BLACK DIAMOND THERAPEUTICS I634,1910-634,1911,8200-1,820
MIRATI THERAPEUTICS INC70,2830-70,2833,0620-3,062
AMBRX BIOPHARMA INC281,0890-281,0893,2330-3,233
ARDELYX INC881,3560-881,3563,5960-3,596
CYTOKINETICS INC(CYTK)223,3820-223,3826,5810-6,581
Page 1 of 1